National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -6 of 6         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Treatment


Active


20 to 85


Other


AMC0183
NCT00689715


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


20 to 70


Other


07-2007-006
NCT00357422


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


20 to 70


Other


07-2006-010
NCT00357474


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Biomarker/Laboratory analysis, Treatment


Active


19 to 70


Other


10-2006-001
NCT00397540


5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Supportive care


Active


18 and over


Other


CCRRC 2007-32
08D.380, NCT00806611

Last Modified: 7/12/2007     First Published: 5/4/2007  

6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Supportive care


Active


6 months and over


NCI


MSKCC-07047
07-047, NCT00471679

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov